Cadila Healthcare, a Rs.6,150 crore Ahmedabad based pharma giant, has posted consolidated net profit growth of 53.6 per cent during the fourth quarter ended March 2013 mainly on account of credit of alternate minimum tax of Rs.58.30 crore as against provision of Rs.43.63 crore in the corresponding period of last year. Its net profit stood at Rs.262.46 as against Rs.170.88 crore. The company's consolidated net sales increased by 16.5 per cent to Rs.1,566 crore from Rs.1,344 crore in the corresponding quarter of last year. Its EBDITA declined marginally to Rs.295.12 crore from Rs.298.19 crore.

The board of directors has recommended an interim dividend of Rs.7.50 per share of Rs.5 each for the year 2012-13. This worked out to 150 per cent. With EBDITA under pressure, the Cadila scrip declined by almost by 2 per cent to Rs.773.15 after the announcement of financial working in the afternoon session on BSE.

For the full year ended March 2013, Cadila's consolidated net sales increased by 20.9 per cent to Rs.6,158 crore from Rs.5,263 crore in the previous year. EBDITA improved only by 2.5 per cent to Rs.1,163 crore from Rs.1,135 crore. Its net profit remained almost unchanged at Rs.655 crore and its EPS worked out to Rs.32.01 as compared to Rs.31.87 in the previous year.

The company filed 33 ANDAs during the year taking the cumulative filings to 173. It received 15 ANDAs approvals during the year taking the total to 76 product approvals. It filed 25 additional dossiers for new products in the European markets, taking the cumulative number of new products dossier filings to 161. The company filed 18 dossiers in Brazil taking the cumulative filings to 100. In Mexico, it filed 6 new product dossiers, taking the cumulative filings to 20.

The company increased its investment in Zydus BSV Pharma Pvt Ltd by Rs.2.50 crore and that in Bayer Zydus Pharma Pvt Ltd by Rs.20 crore during 2012-13. Cadila Healthcare is now amalgamating three wholly owned subsidiaries viz., Liva Healthcare Ltd, Zydus Animal Health Ltd and Zydus Pharmaceuticals Ltd with the company from April 1, 2012.